You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rearranged during transfection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Nonhaematologic Malignancies Trial in Worldwide (BOS172738)

Active, not recruiting
  • Advanced Nonhaematologic Malignancies
  • Philadelphia, Pennsylvania
  • +20 more
Sep 23, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

Active, not recruiting
Has Results
  • Solid Tumor
  • Medullary Thyroid Cancer
  • Guangzhou, Guangdong, China
  • +12 more
May 9, 2022

Irritable Bowel Syndrome Trial in Adelaide (GSK3352589, Matching Placebo)

Completed
Has Results
  • Irritable Bowel Syndrome
  • Adelaide, South Australia, Australia
    GSK Investigational Site
Jun 28, 2019

Resistance-associated Mutations in Metastatic Lung Cancer

Recruiting
  • Lung Cancer
  • Liquid biopsy
  • Monza, MB, Italy
    Fondazione IRCCS San Gerardo dei Tintori
Oct 10, 2023

Medullary Thyroid Cancer Trial in China (Anlotinib Hydrochloride Capsule)

Recruiting
  • Medullary Thyroid Cancer
  • Anlotinib Hydrochloride Capsule
  • Hefei, Anhui, China
  • +18 more
Apr 14, 2023

Metastatic Renal Cell Carcinoma Trial in France (Cabozantinib)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Angers, France
  • +8 more
Dec 5, 2022

Mucosal Melanoma Trial in Wollstonecraft (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Mucosal Melanoma
  • Wollstonecraft, New South Wales, Australia
    Melanoma Institute Australia
Sep 15, 2022

Children and Adults With Medullary Thyroid Cancer

Recruiting
  • Medullary Thyroid Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    NSCLC Trial in Guangzhou (HA121-28 tablet)

    Recruiting
    • NSCLC
    • HA121-28 tablet
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Centre
    Aug 2, 2022

    Resectable Early-stage Non-small Cell Lung Cancer

    Completed
    • Non-small Cell Lung Cancer
      • Alexandria, Egypt
      • +3 more
      Nov 21, 2022

      Thyroid Carcinoma

      Recruiting
      • Differentiated Thyroid Carcinoma
      • Medullary Thyroid Carcinoma
      • Immunohistochemistry (IHC)
      • +2 more
      • L'Hospitalet De Llobregat, Barcelona, Spain
      • +11 more
      Mar 22, 2022

      NSCLC Trial in Worldwide (Selpercatinib, Carboplatin, Cisplatin)

      Active, not recruiting
      • Non-Small Cell Lung Cancer
      • Berazategui, Buenos Aires, Argentina
      • +195 more
      Jan 30, 2023

      NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

      Recruiting
      • Non-Small Cell Lung Cancer
      • +3 more
      • Scottsdale, Arizona
      • +84 more
      Oct 10, 2022

      Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)

      Recruiting
      • Medullary Thyroid Cancer
      • Birmingham, Alabama
      • +148 more
      Jan 18, 2023

      RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

      Active, not recruiting
      • RET-altered Non Small Cell Lung Cancer
      • +39 more
      • pralsetinib (BLU-667)
      • Phoenix, Arizona
      • +65 more
      Nov 10, 2022

      Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

      Not yet recruiting
      • Medullary Thyroid Cancer
      • Cordoba, Spain
      • +1 more
      Jan 11, 2023

      Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

      Not yet recruiting
      • Lung Cancer
      • Non Small Cell Lung Cancer
      • Amivantamab 1050mg
      • +2 more
      • Aurora, Colorado
      • +2 more
      Apr 25, 2023

      Hepatocellular Carcinoma Trial in United States (Regorafenib 40 MG)

      Terminated
      • Hepatocellular Carcinoma
      • Regorafenib 40 MG
      • Gilbert, Arizona
      • +8 more
      Dec 10, 2021

      Melanoma Stage III Trial in North Sydney (Pembrolizumab, Lenvatinib)

      Recruiting
      • Melanoma Stage III
      • North Sydney, New South Wales, Australia
        Melanoma Institute Australia
      Oct 26, 2022

      Medullary Thyroid Cancer Trial (Ponatinib)

      Withdrawn
      • Medullary Thyroid Cancer
      • (no location specified)
      Oct 6, 2021

      NSCLC Stage IIIB, ALK Gene Mutation Trial in Mexico City (Alectinib Oral Product)

      Recruiting
      • Non-small Cell Lung Cancer Stage IIIB
      • ALK Gene Mutation
      • Alectinib Oral Product
      • Mexico City, Mexico
        Thoracic Oncology Unit and Personalized Medicine Laboratory, Ins
      Jan 26, 2023

      Non Small Cell Lung Cancer, Metastatic, Recurrent Trial in United States (Lorlatinib, Ramucirumab)

      Recruiting
      • Non Small Cell Lung Cancer
      • +2 more
      • Middletown, New Jersey
      • +5 more
      Aug 17, 2023

      Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)

      Recruiting
      • Non-Small Cell Lung Cancer
      • Quality of Life Questionnaire-Core 30 (QLQ-C30)
      • Aix En Provence, France
      • +27 more
      Sep 9, 2021

      NSCLC Trial in Davis, San Francisco (Ceritinib, Trametinib)

      Terminated
      • Non-small Cell Lung Cancer
      • Davis, California
      • +1 more
      Dec 22, 2022